Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Piaseczno – page 3

39 clinical trials in Piaseczno, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Piaseczno at a glance
39
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

39 trials in Piaseczno

Open in trial search

Psoriasis

Not recruiting

Study on the Effects and Safety of Piclidenoson for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Piclidenoson
  • Sponsor:Can-Fite Biopharma Ltd.

Study on the Safety and Tolerability of VRDN-003 for Patients with Thyroid Eye Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Study of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Degarelix
  • Sponsor:Debiopharm International SA

Cough

Not recruiting

Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Camlipixant
  • Sponsor:Bellus Health Inc.

Asthma

Not recruiting

Study on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting

Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Cough

Not recruiting

Study on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Camlipixant
  • Sponsor:Bellus Health Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Study of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Viridian Therapeutics Inc.

Study on the Effectiveness and Safety of Adding Pioglitazone to Metformin and Empagliflozin for Patients with Type 2 Diabetes with Poor Blood Sugar Control

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Celltrion Inc.

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Piaseczno

What the registry says about research in the country

01 Respiratory Conditions

Comprehensive research focusing on chronic obstructive pulmonary disease (COPD) and various types of asthma treatments. Clinical trials are evaluating innovative therapies for managing severe respiratory conditions.

  • COPD Management
  • Severe Eosinophilic Asthma
  • Chronic Bronchitis

Studies include testing new bronchodilator combinations and investigating treatments for refractory chronic cough.

02 Cardiovascular Health

Innovative research addressing heart failure and stroke prevention. Clinical trials are exploring new therapeutic approaches for managing cardiac conditions and reducing cardiovascular risks.

  • Heart Failure Prevention
  • Atrial Fibrillation
  • Stroke Prevention

Trials focus on combination therapies and novel compounds for improving cardiovascular outcomes.

03 Metabolic Disorders

Advanced research in Type 2 Diabetes management, exploring combination therapies and new treatment approaches. Studies evaluate various medication combinations for optimal glycemic control.

  • Diabetes Management
  • Glycemic Control
  • Combination Therapies

Focus on improving treatment outcomes for patients with inadequately controlled diabetes.

04 Autoimmune Conditions

Research investigating treatments for thyroid eye disease and inflammatory conditions. Studies evaluate new biological therapies and their effectiveness in managing autoimmune disorders.

  • Thyroid Eye Disease
  • Plaque Psoriasis
  • Ulcerative Colitis

Trials assess both established and novel therapeutic approaches for inflammatory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.